Meridian Bioscience

Meridian Bioscience is a life science company which develops, manufactures, distributes, and sells diagnostic test kits primarily for various gastrointestinal and viral diseases, respiratory and parasitic infectious diseases, and elevated blood lead levels worldwide. The Company offers testing platforms and technologies. These products are primarily used in the detection of infectious diseases caused by various bacteria, viruses, parasites, and pathogens.The Company also provides bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies.

Company Growth (employees)
Cincinnati, US
Size (employees)
640 (est)-1%
Meridian Bioscience was founded in 1977 and is headquartered in Cincinnati, US

Meridian Bioscience Office Locations

Meridian Bioscience has offices in Cincinnati, Memphis, London, Luckenwalde and in 5 other locations
Cincinnati, US (HQ)
3471 River Hills Drive
Memphis, US
5171 Wilfong Road
Braine-l'Alleud, BE
2 Avenue du Japon
Paris, FR
34 Rue de Ponthieu
Milano, IT
7 Via dell'Industria
London, GB
16 Edge Business Centre Humber Rd
Show all (9)

Meridian Bioscience Financials and Metrics

Meridian Bioscience Financials

Meridian Bioscience's revenue was reported to be $200.8 m in FY, 2017

Revenue (FY, 2017)

200.8 m

Gross profit (FY, 2017)

124.8 m

Gross profit margin (FY, 2017), %


Net income (FY, 2017)

21.6 m

EBIT (FY, 2017)

37.4 m

Market capitalization (16-Feb-2018)

618.6 m

Cash (30-Sep-2017)

57.1 m


616.2 m
Meridian Bioscience's current market capitalization is $618.6 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017


188.7 m188.8 m194.8 m196.1 m200.8 m

Revenue growth, %


Cost of goods sold

67.6 m71.6 m72.9 m68.3 m75.9 m

Gross profit

121 m117.2 m121.9 m127.8 m124.8 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


44.8 m50.1 m47.2 m48 m51.5 m48.2 m47.2 m51.3 m50.7 m46.8 m54.1 m50.1 m

Cost of goods sold

16.8 m18.5 m18 m18.8 m19 m17.9 m15.6 m17.7 m17.8 m17.4 m20.6 m18.9 m

Gross profit

28 m31.6 m29.2 m29.2 m32.5 m30.3 m31.6 m33.6 m32.9 m29.5 m33.5 m31.2 m

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017


44.3 m43 m50 m47.2 m57.1 m


34.8 m35.5 m35.8 m45.1 m41.5 m

Current Assets

114.1 m112.7 m122.9 m126.8 m133.9 m


23.1 m23.2 m22.3 m62 m54.9 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017


43.7 m38.2 m39.3 m49.5 m42.7 m46 m53.4 m48.9 m45.8 m49.3 m54.7 m55.3 m


37.7 m38.1 m37.6 m34.4 m33 m33.6 m38.8 m41.9 m43.4 m44.7 m42.4 m40.9 m

Current Assets

111.2 m114 m113.5 m114.7 m116.5 m118 m123.2 m128.2 m126.9 m126 m128.8 m129.2 m


23.4 m23.5 m23.8 m22.6 m22.1 m22.8 m22.1 m64.5 m63.7 m60.7 m60.8 m54.6 m
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    38 m34.7 m35.5 m32.2 m21.6 m


    41.5 m

    Accounts Payable

    7.7 m

    Cash From Operating Activities

    44.4 m38.3 m42.8 m37.2 m41.4 m
    USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Net Income

    7.4 m10.3 m8.8 m7.9 m10.1 m27.1 m8.9 m18 m26.7 m6.3 m15.6 m15.8 m


    33.6 m38.8 m41.9 m43.4 m44.7 m42.4 m

    Accounts Payable

    5.5 m7.2 m7.9 m7.4 m7.5 m6.4 m

    Dividends Paid

    (25 m)(8.4 m)(16.8 m)(25.2 m)(8.4 m)(13.7 m)(19 m)
      USDY, 2017


      16.5 x


      14.9 x


      310.5 k


      0.3 x


      0.2 x

      Financial Leverage

      1.5 x
      Show all financial metrics

      Meridian Bioscience Market Value History

      Meridian Bioscience's Web-traffic and Trends

      Meridian Bioscience Online and Social Media Presence

      Meridian Bioscience Company Life and Culture

      You may also be interested in